(Q44620888)

4 December 2017

title

Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit (English)

1 reference

4 December 2017

1 reference

Lucy B Palmer

1

1 reference

4 December 2017

Gerald C Smaldone

series ordinal

2

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 May 2014

1 reference

American Journal of Respiratory and Critical Care Medicine

4 December 2017

published in

1 reference

4 December 2017

volume

189

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

1225-1233

1 reference

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201312-2161OC

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201312-2161OC

The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201312-2161OC

International study of the prevalence and outcomes of infection in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201312-2161OC

Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201312-2161OC

Aerosol delivery and modern mechanical ventilation: in vitro/in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201312-2161OC

Aerosolized antibiotics in critically ill ventilated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201312-2161OC

Impact of antibiotic MIC on infection outcome in patients with susceptible Gram-negative bacteria: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201312-2161OC

BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201312-2161OC

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201312-2161OC

Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201312-2161OC

Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201312-2161OC

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201312-2161OC

Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201312-2161OC

Disposition of instilled versus nebulized tobramycin and imipenem in ventilated intensive care unit (ICU) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201312-2161OC

Ventilator-associated pneumonia: diagnosis, treatment, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201312-2161OC

10.1164/RCCM.201312-2161OC

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference